PedAM
Pediatric Disease Annotations & Medicines
| Disease | schizophrenia |
| Symptom | C0796095|c syndrome |
| Sentences | 48 |
| PubMedID- 24661388 | The cohorts varied in sample size (from hundreds to over half a million participants), in methodology and in the outcomes studied (height, overweight and obesity, glucose metabolism and diabetes, hypertension, metabolic syndrome, quality of life, schizophrenia, socioeconomic parameters etc.). |
| PubMedID- 21791046 | This study aimed to investigate the degree that antipsychotic polypharmacy contributed to metabolic syndrome in outpatients with schizophrenia, after adjustment for the effects of lifestyle. |
| PubMedID- 21105277 | The prevalence of the metabolic syndrome is increased in patients with schizophrenia compared with the general population. |
| PubMedID- 22541717 | Increased level of serum cytokines, chemokines and adipokines in patients with schizophrenia is associated with disease and metabolic syndrome. |
| PubMedID- 24955550 | Saffron aqueous extract prevents metabolic syndrome in patients with schizophrenia on olanzapine treatment: a randomized triple blind placebo controlled study. |
| PubMedID- 23286356 | schizophrenia patients with metabolic syndrome (mets) (35%) had a 23.9% lower (p<0.001) sbj-score and 22.4% (p<0.001) lower 6mwt-score than those without mets. |
| PubMedID- 23882141 | The prevalence of metabolic syndrome in patients with schizophrenia from this study (39% in females, 35% in males) was slightly lower than that reported from the us clinical antipsychotic trials of intervention effectiveness (catie) study, which found the prevalence to be 52% in females and 36% in males, but was higher than the overall rate of 32.5% from a meta-analysis by mitchell et al.22,23 the difference in prevalence might be explained by racial/ethnic heterogeneity, environmental factors, dietary consumption, and the criteria of metabolic syndrome used.24 the higher prevalence of metabolic syndrome in females found in our study was in line with that reported in the catie study22, although the sex difference in this study was not statistically significant. |
| PubMedID- 23337566 | Conclusion: the prevalence of metabolic syndrome in schizophrenia patients receiving antipsychotic monotherapy in malaysia was very high. |
| PubMedID- 22986004 | schizophrenia is statistically associated with metabolic syndrome, hypertension, and migraine because they form a cluster of diseases with similar pathophysiology. |
| PubMedID- 23138143 | Prevalence of metabolic syndrome among patients with schizophrenia in singapore. |
| PubMedID- 21772644 | Drug-emergent metabolic syndrome in patients with schizophrenia receiving atypical (second-generation) antipsychotics. |
| PubMedID- 25034455 | Is abnormal non-high-density lipoprotein cholesterol a gender-specific predictor for metabolic syndrome in patients with schizophrenia taking second-generation antipsychotics. |
| PubMedID- 25917886 | The principal objective of this study was to investigate the relationship between sensory gating deficit and metabolic syndrome in patients with schizophrenia, after adjusting for key confounding factors. |
| PubMedID- 22869990 | (c)obesity and metabolic syndrome coexist with schizophrenia with or occasionally even without concurrent drug therapy. |
| PubMedID- 21398211 | In this article i review the theoretical and practical aspects of the comorbidity of schizophrenia with metabolic syndrome and diabetes mellitus. |
| PubMedID- 20425584 | Metabolic syndrome associated with schizophrenia and atypical antipsychotics. |
| PubMedID- 22592510 | A possible stratification of the risk of metabolic syndrome in patients with schizophrenia receiving atypical antipsychotic drugs is as follows: minimal-risk societies are constituted by societies living in eastern asian countries, whereas intermediate-risk societies are constituted by societies living in western asia and south america, and high-risk societies are societies living in australia. |
| PubMedID- 22154487 | Metabolic syndrome in patients with schizophrenia independently from atypical antipsychotics intake. |
| PubMedID- 21994515 | In this cross-sectional study, we investigated whether htr2c-759c/t, htr2c-697g/c, pparalpha v227a, and ppargamma 161c/t genotypes were associated with metabolic syndrome (mets) in patients with schizophrenia taking clozapine. |
| PubMedID- 22970386 | To improve quality of life and decrease metabolic syndrome in patients with schizophrenia, it is essential for caregivers to support patients' drug administration with a minimal effective dose, and aripiprazole is considered to be one of the most effective options available. |
| PubMedID- 22120854 | Prevalence of diabetes, obesity, and metabolic syndrome in subjects with and without schizophrenia (cures-104). |
| PubMedID- 23960421 | 5 the risk of metabolic syndrome induction in patients with schizophrenia seems to be increased by every class of antipsychotic drugs administered, with atypical drugs being more risky than typical antipsychotic drugs. |
| PubMedID- 22503355 | Prevalence of metabolic syndrome in patients with schizophrenia in india. |
| PubMedID- 24837425 | Metabolic syndrome is associated with both schizophrenia and antipsychotic medication, especially clozapine, with alterations in inflammatory cytokines and adipokines. |
| PubMedID- 26041435 | Particularly, cognitive impairment, a core symptom of schizophrenia, is associated with metabolic syndrome5758 and chronic inflammation19. |
| PubMedID- 21477998 | Psychopathology, coronary heart disease and metabolic syndrome in schizophrenia spectrum patients with deficit versus non-deficit schizophrenia: findings from the clamors study. |
| PubMedID- 23341251 | Detection of metabolic syndrome in schizophrenia and implications for antipsychotic therapy : is there a role for folate. |
| PubMedID- 23188979 | 2 found that the age-adjusted prevalence of metabolic syndrome in patients with schizophrenia was 40.9%, based on the criteria from the third report of the national cholesterol education program's expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel iii) (ncep atp iii). |
| PubMedID- 26469976 | Recent evidence has shown that schizophrenia is closely associated with hypertension , obesity , and dyslipidemia . |
| PubMedID- 26001844 | It has been estimated that the prevalence of metabolic syndrome in patients with schizophrenia may be as high as one in three 7. |
| PubMedID- 23270504 | Prevalence of metabolic syndrome among patients with schizophrenia in palestine. |
| PubMedID- 25568478 | Cardiac risk factors and metabolic syndrome in patients with schizophrenia admitted to a general hospital psychiatric unit. |
| PubMedID- 20683849 | The objective of this multinational, cross-sectional, pharmacoepidemiological study was to determine the prevalence of diabetes, lipid disorders, obesity, hypertension and the metabolic syndrome in patients with schizophrenia treated with antipsychotic drugs. |
| PubMedID- 22754543 | Finally, preliminary evidence suggests that folate supplementation, which may restore balance of the aldo met cycle, improves endothelial function in schizophrenia patients with metabolic syndrome (ellingrod et al., 2012). |
| PubMedID- 22796278 | Moreover, strategies to reduce inflammation and obesity may prevent metabolic syndrome in patients with schizophrenia who take atypical antipsychotic medication. |
| PubMedID- 20643418 | The results support the utility of screening and genetic testing to identify genetic syndromes in adults with schizophrenia in clinical practice. |
| PubMedID- 22926590 | Higher prevalence rates of metabolic syndrome (mets) in patients with schizophrenia are getting more and more attention. |
| PubMedID- 24647221 | The aim of this study was to investigate the characteristics of cognitive function damage in chronic schizophrenia patients with metabolic syndrome (ms); 388 patients were divided into two groups: ms group (180 people with schizophrenia and ms) and non-ms group (208 people with schizophrenia but without ms). |
| PubMedID- 20850274 | Prevalence of metabolic syndrome among patients with schizophrenia in japan. |
| PubMedID- 26004686 | We aimed to determine the prevalence of metabolic syndrome among patients with schizophrenia who were antipsychotic drug-naive or drug-free and their siblings for comparison with healthy controls. |
| PubMedID- 25126357 | Objectives: to summarize the current literature on atypical antipsychotic-induced metabolic syndrome in patients with schizophrenia, outline some of the molecular mechanisms behind this syndrome, identify demographic and disease-related risk factors, and describe cost-effective methods for surveillance. |
| PubMedID- 22044502 | Prevalence of metabolic syndrome in patients with schizophrenia, and metabolic changes after 3 months of treatment with antipsychotics--results from a german observational study. |
| PubMedID- 22747854 | Predictive utility of blood pressure, waist circumference and body mass index for metabolic syndrome in patients with schizophrenia in singapore. |
| PubMedID- 21185157 | Association between htr2c polymorphisms and metabolic syndrome in patients with schizophrenia treated with atypical antipsychotics. |
| PubMedID- 26093599 | The stabilizing effect of dehydroepiandrosterone on clinical parameters of metabolic syndrome in patients with schizophrenia treated with olanzapine - a randomized, double-blind trial. |
| PubMedID- 24204153 | Sod2 also plays crucial roles in antioxidant defense mechanisms.31 the val16ala polymorphism has been linked to cardiovascular disease and to type 2 diabetes and its complications in the general population, but studies so far have yielded conflicting results.28,29,33 in the present study, we did not find any significant associations between the sod2 genotype and the risks of being overweight and having metabolic syndrome in patients with schizophrenia or controls. |
| PubMedID- 22841467 | Metabolic syndrome in patients with schizophrenia and antipsychotic treatment. |
| PubMedID- 23153955 | The aetiology of the metabolic syndrome in schizophrenia is multi-factorial and may involve antipsychotic treatment, high levels of stress and unhealthy lifestyle, such as poor diet. |
Page: 1